You are currently viewing a new version of our website. To view the old version click .
by
  • Bhoomi Dave1,2,
  • Monica Patel1 and
  • Sruthi Suresh1
  • et al.

Reviewer 1: Mohammadreza Aghamirsalim Reviewer 2: Anonymous Reviewer 3: Anonymous

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

 I found this manuscripg very intersting manuscript  and this systematic review was siutabla for publication .

Author Response

Thank you so much for your comments. We appreciate your kind remarks and your approval of our manuscript.

Reviewer 2 Report

Comments and Suggestions for Authors

see attached

Comments for author File: Comments.pdf

Comments on the Quality of English Language

The English is OK.

Author Response

We really appreciate your comments! Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 3 Report

Comments and Suggestions for Authors

This is an excellent review describing techniques and pitfalls of glaucoma surgical treatments. Having myself had a past interest in this field, I may only suggest a further addition to their list of potential innovative treatments to control filtration surgery. The work published in 2023 by Minnelli et al. (DOI: 10.3390/ph16040594) described the effects of Meldonium on the control of IOP and simultaneously interfering with the fibrotic reaction after glaucoma filtration surgery (GFS). Therefore, the use of meldonium as eye drops in a trans-epithelial formulation with nanomicelles might represent a novel conservative treatment after GFS, prolonging the hypotonizing effects of the surgical intervention and adding a further relevant hypotonizing effect, with minimal risk of doping effects in treated patients.

Author Response

Thank you so much for your comments. We appreciate your kind remarks.